⌘K

Login Start Free

Home/Filings/4/0001127602-23-003509

4//SEC Filing

PENDARVIS DAVID 4

Accession 0001127602-23-003509

CIK 0000943819other

View on SEC.gov Company Profile

Filed

Feb 5, 7:00 PM ET

Accepted

Feb 6, 1:55 PM ET

Size

4.3 KB

Accession

0001127602-23-003509

Insider Transaction Report

Form 4

Period: 2023-02-03

PENDARVIS DAVID

Sr. VP, General Counsel

Transactions

Sale
ResMed Common Stock
2023-02-03$224.50/sh−1,500$336,750→ 95,672 total

Footnotes (1)

[F1]The transaction was conducted under a Rule 10b5-1 plan.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

RESMED INC

CIK 0000943819

Entity typeother

Related Parties

1

filerCIK 0001196723

Filing Metadata

Form type: 4
Filed: Feb 5, 7:00 PM ET
Accepted: Feb 6, 1:55 PM ET
Size: 4.3 KB

View on SEC.gov